Phialophora parasitica, an emerging pathogen
- PMID: 6095471
- DOI: 10.1080/00362178485380541
Phialophora parasitica, an emerging pathogen
Abstract
Monoconidial cultures derived from 12 clinical and environmental isolates of Phialophora parasitica were compared with respect to morphologic and physiologic characteristics and response to antifungal agents. No yeast cells were seen in 1- and 3-week-old slide culture preparations. Also, not all of the distinguishing characteristics of this species were displayed by all isolates on all media examined. Although the isolates grew on Sabouraud agar with chloramphenicol and cycloheximide, some inhibition was observed. All cultures were strongly urease-positive and hydrolyzed casein and starch; most decomposed tyrosine but not gelatin. All but one environmental isolate grew well at both 23 and 37 degrees C, but none grew at 40 degrees C. In the sensitivity testing the isolates did not vary much in their response to each drug, although some anomalies were observed. Amphotericin B and miconazole had minimum inhibitory concentrations in the low sensitivity range (2.0-8.0 and 2.5-10 micrograms m-1 respectively), for most isolates, and most isolates were resistant to both 5-fluorocytosine and ketoconazole. Limited observations were made on three other Phialophora species which might be confused with P. parasitica.
Similar articles
-
Subcutaneous infection with phialophora richardsiae and its susceptibility to 5-fluorocytosine, amphotericin B and miconazole.Sabouraudia. 1980 Jun;18(2):97-104. Sabouraudia. 1980. PMID: 7423334
-
Phialophora richardsiae isolated from infected human bone: morphological, physiological and antifungal susceptibility studies.Mycopathologia. 1984 May 30;86(2):103-11. doi: 10.1007/BF00436495. Mycopathologia. 1984. PMID: 6738670
-
Susceptibility of clinical isolates of Fusarium to antifungal drugs.Mycoses. 1996 Jan-Feb;39(1-2):37-40. doi: 10.1111/j.1439-0507.1996.tb00081.x. Mycoses. 1996. PMID: 8786755
-
Disseminated Phialophora parasitica infection in humans: case report and review.Rev Infect Dis. 1989 Sep-Oct;11(5):770-5. doi: 10.1093/clinids/11.5.770. Rev Infect Dis. 1989. PMID: 2682949 Review.
-
Acremonium species: new emerging fungal opportunists--in vitro antifungal susceptibilities and review.Clin Infect Dis. 1997 Nov;25(5):1222-9. doi: 10.1086/516098. Clin Infect Dis. 1997. PMID: 9402385 Review.
Cited by
-
Evaluation of proteolytic activity to differentiate some dematiaceous fungi.J Clin Microbiol. 1988 Feb;26(2):301-7. doi: 10.1128/jcm.26.2.301-307.1988. J Clin Microbiol. 1988. PMID: 3343325 Free PMC article.
-
Species of Phaeoacremonium associated with infections in humans and environmental reservoirs in infected woody plants.J Clin Microbiol. 2005 Apr;43(4):1752-67. doi: 10.1128/JCM.43.4.1752-1767.2005. J Clin Microbiol. 2005. PMID: 15814996 Free PMC article.
-
Phialophora repens, an emerging agent of subcutaneous phaeohyphomycosis in humans.J Clin Microbiol. 1989 Mar;27(3):394-9. doi: 10.1128/jcm.27.3.394-399.1989. J Clin Microbiol. 1989. PMID: 2715315 Free PMC article.
-
Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens.Antimicrob Agents Chemother. 1993 Nov;37(11):2407-11. doi: 10.1128/AAC.37.11.2407. Antimicrob Agents Chemother. 1993. PMID: 8285625 Free PMC article.
-
Microbiology and potential virulence of Sporothrix cyanescens, a fungus rarely isolated from blood and skin.J Clin Microbiol. 1990 May;28(5):1009-15. doi: 10.1128/jcm.28.5.1009-1015.1990. J Clin Microbiol. 1990. PMID: 2351719 Free PMC article.